Engineering of CAR-T cells to react against gp350+ cells infected with Epstein-Barr Virus : proof-of-concepts in vitro and in vivo
Preview
Cite
Access Statistic
Rights
Use and reproduction:
All rights reserved
Use and reproduction:
All rights reserved